Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 2,626 shares at $94.82 ($249K) on 2022-02-18, disclosed to the SEC on 2022-02-18.
Open-market sale of $249k HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.82 | 1,313 | $124K | 50.0% |
| 2 | $94.82 | 1,313 | $124K | 50.0% |
| Total | $94.82 avg | 2,626 | $249K | 100% |
| Filing → |
| HZNP | SELL | 2022-07-29 | $801K | — | Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-01-06 | $1.4M | — | Filing → |